Navigation Links
Scientists Probe Sepsis' Deadly Secrets
Date:8/18/2007

Inflammatory condition is 10th leading killer in United States, experts say

FRIDAY, Aug. 17 (HealthDay News) -- Even when they appear clinically similar, patients with potentially deadly sepsis may be having different kinds of immune responses, say U.S. researchers who conducted the first large-scale natural history study of the common condition.

Sepsis -- a result of the body's inflammatory response to infection -- can lead to organ failure and death. Almost one million people in the United States will develop sepsis this year, and about 30 percent will die, making it the 10th leading cause of death in the country.

The University of Pittsburgh team said its findings suggest that past interpretations of how the immune system responds to infection were incorrect, because they were based on data from small studies. As a result, most of the treatments based on those studies have proven ineffective.

For this study, the University of Pittsburgh team evaluated data from almost 1,900 patients hospitalized with community-acquired pneumonia (CAP), the leading cause of severe sepsis. More than 30 percent of the patients developed severe sepsis, and 26 percent of those patients died.

The researchers found that 82 percent of the CAP patients had elevated cytokine levels, which were highest among those with fatal severe sepsis and lowest among those with no sepsis. Cytokines are signaling proteins especially involved in immune and inflammatory processes.

The study was published this week in the journal Archives of Internal Medicine.

"Our data show that much of what we previously thought about the role of the inflammatory response plays in sepsis was wrong or incomplete," Dr. John A. Kellum, professor in the department of critical care at the University of Pittsburgh School of Medicine, said in a prepared statement.

"We had thought the inflammatory response to infection was relatively short-lived, just a few days, and that it was similar in patients with similar clinical signs. Instead, we found that the inflammatory response was extremely variable across patients -- more than 50-fold differences were seen in some markers. Additionally, we found that the inflammatory response extends past the outward symptoms, far longer than previous data would suggest, and far longer than the courses of therapies used in unsuccessful clinical trials of experimental agents," Kellum said.

"We also found that the difference between the inflammatory response in a patient with a good outcome and a patient with a bad outcome is only a matter of degree."

Kellum and his colleagues said their findings indicate that treatments that completely abolish a specific component of the inflammatory response would be ineffective, and possibly even dangerous, because the inflammatory response is needed to deal with a patient's underlying infection.

Instead, better results might be achieved using therapies that tackle the chronic inflammatory response after sepsis and therapies that address multiple components.

More information

The MedlinePlus Medical Encyclopedia has more about sepsis.



-- Robert Preidt



SOURCE: University of Pittsburgh Schools of the Health Sciences, news release, Aug. 13, 2007


'/>"/>

Copyright©2007 ScoutNews,LLC.

Related medicine news :

1. Nobel Prize for Medicine shared by Three scientists
2. Scientists plan human cloning clinic in the United States
3. Scientists crack dengue fever puzzle
4. Scientists found ancient Human Germ Killer
5. Scientists locate key hormone involved in appetite control
6. Scientists open the book of life
7. Electronic nose by Italian scientists
8. Scientists review SARS
9. Scientists push to lower hidden sodium in food
10. Indian Scientists Make Wide-Ranging Analysis And Annotation Of X Chromosome
11. Scientists have found effective brain regions for deep brain stimulation for Parkinson’s
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2018)... ... December 05, 2018 , ... Northeast Delta ... January 26 at North Monroe Baptist Church, 210 Finks Hideaway Rd, Monroe, LA ... the agency’s effort to educate and equip faith leaders to address substance abuse ...
(Date:12/5/2018)... ... 05, 2018 , ... What is Rosacea: , Rosacea is ... It manifests on the face, especially the cheeks, chin, nose and mid forehead. ... and psychological problems. , Although it is considered incurable, the use of appropriate ...
(Date:12/5/2018)... ... December 05, 2018 , ... Domenic Palmieri has been ... he will be responsible for the executive oversight of operations for three core ... nationwide search for this position,” Tom Doran, president, HM Insurance Group, said. “And ...
(Date:12/5/2018)... ... December 05, 2018 , ... To change ... Unitek’s transformative conference at the DoubleTree Hilton Hotel in Newark, California. Led by ... and Founder/Director of Watson Caring Science Institute, participants and esteemed guests discussed the ...
(Date:11/29/2018)... ... November 29, 2018 , ... The National Association ... in the Future: Why Preventing Chronic Disease is Essential - Prevention Works ,” ... control, and health promotion. , The paper outlines some of the strongest ...
Breaking Medicine News(10 mins):
(Date:12/6/2018)... YORK (PRWEB) , ... December 06, 2018 , ... It’s easy to get sick during ... family follows. According to the CDC, someone with the flu can spread it to others ... droplets made when people with the flu cough, sneeze or talk. While most people recover ...
(Date:12/5/2018)... ... ... Trivellini Tech announces the latest version of Trivellini system and it ... Nano, Trivellini Long Hair introduces the ability to harvest long hair grafts during FUE ... capabilities as the last generation but it can also be programmed to extract long ...
(Date:12/5/2018)... (PRWEB) , ... December 05, 2018 , ... ... Nuanced Cyber Regulatory Waters , **An FDAnews Webinar**, Tuesday, Dec. 18, 2018, ... devices get, the more vulnerable they become. , Cybersecurity is becoming an everyday ...
Breaking Medicine Technology: